Richardson added, "With liquidity of $475 million and a net debt to EBITDA of 1.9x, we have ample financial capacity to pursue strategic acquisitions, invest in innovation and continue our share repurchases and dividends." Liquidity is calculated as follows: Liquidity

Liquidity and Capital Resources Our objective is to finance our business through operating cash flow and the appropriate mix of debt. By diversifying the maturity structure, we avoid concentrations of debt, reducing liquidity risk. Cash and Cash Equivalents We consider all highly liquid investments purchased with a maturity of less than three months to be cash equivalents.

Sustainability performance recognized with a Gold Medal for EcoVadis, and with an ARanking for CDP Climate Change

Standard shades include Brilliant Rose Gold, Brilliant Ice Blue, Brilliant Silver and Brilliant Gun Metal, but virtually any hue can be customized for specific applications.

At Packaging of Perfume Cosmetics & Design (PCD, booth #AB17), the company is illustrating the impact of soft-touch TPEs with gold, silver and copper effects and featuring an inspirational portfolio based on the 2017 InVisiOSM Color Inspiration Wanderlust collection from PolyOne Color and Additives. 

Standard shades include Brilliant Rose Gold, Brilliant Ice Blue, Brilliant Silver and Brilliant Gun Metal, but virtually any hue can be customized for specific applications.

The gold standard for enhancing polymer performance in medical applications.

By laddering the maturity structure, we avoid concentrations of debt maturities, reducing liquidity risk. The following table summarizes our liquidity as of December 31, 2015: Cash and cash equivalents $279.8 Revolving credit availability 341.9 Liquidity $621.7 As of December 31, 2015, 70% of the Company’s cash and cash equivalents resided outside the United States. Expected sources of cash in 2016 include cash from operations and available liquidity under our revolving credit facility, if needed.

By laddering the maturity structure, we avoid concentrations of debt maturities, reducing liquidity risk. The following table summarizes our liquidity as of December 31, 2016: Cash and cash equivalents $ 226.7 Revolving credit availability 386.2 Liquidity $ 612.9 As of December 31, 2016, 83% of the Company’s cash and cash equivalents resided outside the United States. Expected sources of cash in 2017 include cash from operations and available liquidity under our revolving credit facility, if needed.

Mevopur color and performance concentrates as well as ready-to-use formulations add value to a wide range of applications: MEDICAL DEVICES • Drug delivery • Catheters • Renal care/dialysis • Surgical instruments • Dental instruments • Medical device packaging • Electronic instruments and accessories for monitoring PHARMACEUTICAL PACKAGING • Vials, ampoules • Bottles for pills, liquid medicines • Blister packaging IN VITRO DIAGNOSTICS (IVD) • Blood analysis • IVD devices • IVD disposables (e.g., pipette tips) • Point-of-Care To meet various manufacturing processes, colorants and functional additives are provided as concentrates for dilution into the polymer or as ready-to-use formulations.